Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Henry Krebs

Diagnostic Radiology Newnan, GA Medical Doctor

NPI 1043298243 CMS profile 137522

600 Celebrate Life Pkwy, Cancer Treatment Centers Of America, Newnan, GA 30265

Open in the dashboard

General payments

$30,707

288 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$19,173 paid to institutions, not to them · program years 2022–2023

Through program year 2025, Henry Krebs of Newnan, GA is reported in the CMS Open Payments database as having received $30,707 across 288 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $19,173 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,862 28
2024 General $1,593 30
2023 General $7,053 57
2022 General $1,436 34
2021 General $3,321 14
2020 General $5,559 22
2019 General $9,884 103

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Henry Krebs
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Henry Krebs were reported at $1,862. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Henry Krebs Diagnostic Radiology median Middle half National median
2019 $9,884 $108 $29–$318 $163
2020 $5,559 $65 $21–$252 $114
2021 $3,321 $92 $24–$292 $132
2022 $1,436 $104 $29–$294 $149
2023 $7,053 $110 $29–$337 $160
2024 $1,593 $113 $30–$356 $164
2025 $1,862 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $12,137 18 payments
  2. Surefire Medical, Inc. $7,399 79 payments
  3. Sirtex Medical Inc $1,997 29 payments
  4. Varian Medical Systems, Inc. $1,492 3 payments
  5. Galil Medical Inc. $1,350 1 payment
  6. Siemens Medical Solutions USA, Inc. $1,273 29 payments
  7. Instylla Inc. $595 5 payments
  8. Ethicon US, LLC $466 2 payments
  9. AstraZeneca Pharmaceuticals LP $361 16 payments
  10. Bard Peripheral Vascular, Inc. $320 2 payments
  11. Other $3,317 104 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $13,605 9 payments
  2. Food and Beverage $9,374 255 payments
  3. Travel and Lodging $3,833 15 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,595 8 payments
  5. Honoraria $300 1 payment
Products named General payments · program years 2019–2025
  1. TRINAV INFUSION SYSTEM $7,399 79 payments
  2. General Therapies $5,294 9 payments
  3. GENERAL IO ABLATION $2,500 1 payment
  4. GENERAL - IO ABLATION $2,250 2 payments
  5. ICEFX Interventional Oncology $1,350 1 payment
  6. SIR-Spheres Microspheres $1,201 22 payments
  7. GENERAL - VASCULAR INTERVENTION $1,000 1 payment
  8. LAVA LES (Liquid Embolic System) $795 7 payments
  9. ICEfx Interventional Oncology $675 1 payment
  10. Varian CRYOCARE TOUCH System $614 7 payments
  11. Other $5,753 178 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

35

Median for Diagnostic Radiology: 24

Drug cost

$439

Median for Diagnostic Radiology: $190

Branded share of claims

51.4%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 18 $258
Hydromorphone Hcl Generic 17 $181

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$109,348

Medicare's payments for the services billed

Medicare patients

958

Average age 71

Services billed

2,660

556 women, 402 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 73%
Arthritis 54%
Diabetes 34%
Ischemic heart disease 29%
Chronic kidney disease 29%
COPD 26%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

288 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record